Provider Groups Oppose 340B Provisions in Committee Chair’s Drug Shortage Bill
Draft legislation that would exclude some generics from 340B and focus on penny pricing recently drew criticism from provider advocates. [...]
*Sign up for news summaries and alerts from 340B Report